Benchmark restated their buy rating on shares of Select Medical (NYSE:SEM – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. They currently have a $48.00 target price on the health services provider’s stock.
Separately, Bank of America assumed coverage on shares of Select Medical in a research note on Tuesday, August 20th. They set a “buy” rating and a $42.00 price target for the company. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $39.00.
Check Out Our Latest Analysis on SEM
Select Medical Stock Performance
Select Medical (NYSE:SEM – Get Free Report) last posted its quarterly earnings results on Thursday, August 1st. The health services provider reported $0.60 earnings per share for the quarter, missing the consensus estimate of $0.61 by ($0.01). The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 17.56%. Select Medical’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.61 EPS. On average, sell-side analysts expect that Select Medical will post 2.03 earnings per share for the current year.
Select Medical Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th will be paid a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.39%. The ex-dividend date of this dividend is Wednesday, November 13th. Select Medical’s payout ratio is currently 23.36%.
Institutional Trading of Select Medical
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. grew its position in shares of Select Medical by 5.3% during the 1st quarter. Vanguard Group Inc. now owns 12,997,891 shares of the health services provider’s stock valued at $391,886,000 after purchasing an additional 650,093 shares in the last quarter. Point72 Asset Management L.P. increased its stake in Select Medical by 179.5% in the 2nd quarter. Point72 Asset Management L.P. now owns 843,528 shares of the health services provider’s stock worth $29,574,000 after acquiring an additional 541,728 shares during the last quarter. Millennium Management LLC boosted its position in shares of Select Medical by 183.9% during the 2nd quarter. Millennium Management LLC now owns 679,522 shares of the health services provider’s stock valued at $23,824,000 after acquiring an additional 440,140 shares during the last quarter. Hood River Capital Management LLC purchased a new position in shares of Select Medical during the second quarter worth about $14,819,000. Finally, Ceredex Value Advisors LLC bought a new position in shares of Select Medical in the 2nd quarter worth $11,456,000. 89.48% of the stock is currently owned by institutional investors.
Select Medical Company Profile
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
See Also
- Five stocks we like better than Select Medical
- Market Cap Calculator: How to Calculate Market Cap
- Battle of the Retailers: Who Comes Out on Top?
- Learn Technical Analysis Skills to Master the Stock Market
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.